Drug Markets/Umeclidinium

Umeclidinium

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Umeclidinium is used to treat chronic bronchitis and pulmonary emphysema, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Umeclidinium is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $10.28 to $11.30 per EA — a 10% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$10.28 – $11.30

per EA

7d Activity

1↑0 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing UMECLIDINIUM

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
INCRUSE ELLIPTA 62.5 MCG INH
$11.2992
per EA
+0.05%
INCRUSE ELLIPTA 62.5 MCG INH
$10.2771
per EA
0.00%

Frequently Asked Questions

What is Umeclidinium used to treat?

Umeclidinium is used to treat chronic bronchitis and pulmonary emphysema, per the National Library of Medicine's MED-RT classification.

How many Umeclidinium products are on the market?

The Umeclidinium drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Umeclidinium?

NADAC reference prices for Umeclidinium range from $10.2771 to $11.2992 per EA — a 10% difference between cheapest and most expensive.

Which manufacturers make Umeclidinium?

1 manufacturer lists Umeclidinium in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (2).

How has the price of Umeclidinium changed recently?

Over the past 7 days, 1 Umeclidinium NDC rose and 0 fell, with a market-wide average change of +0.0%.